sabrina galdo novo

Dr
sabrina
galdo novo

WOAH REFERENT FOR FMDV - COORDINATOR ANIMAL HEALTH , DIRECTORATE OF ANIMAL LABORATORY, SENASA, ARGENTINA
SENASA ARGENTINA
LinkedIn 
View profile
Biography
https://www.researchgate.net/profile/Sabrina-Galdo-Novo?ev=hdr_xprf&_tp=eyJjb250ZXh0Ijp7ImZpcnN0UGFnZSI6ImhvbWUiLCJwYWdlIjoiaG9tZSIsInBvc2l0aW9uIjoiZ2xvYmFsSGVhZGVyIn19
Research interests
VIROLOGY FIELD GENETIC AND ANTIGENIC CHARACTERIZATION VACCINOLOGY REGISTRATION, LICENCING AND R+D ACTIVITIES NEW VIRAL CHALLENGES NEW VACCINE PLATFORMS
Projects you're working on
CORRELATION OF IN VIVO IN VITRO CLINICAL TRIALS FOR POTENCY/EFFICACY ASSESMENT HIPERIMMUNE PANELS SERA OF REFERENCE VACCINE MATCHIGN ANTIGENIC AND GENETIC CHARACTIZATION FOR VACCINE USE RECOMMENDATION NEW TECHNOLOGIES OF REPLACEMENT OF ANIMAL USEA AND OLD IN VITRO TECHNIQUES EPITOPE MAPPING FOR ASSESSING IMMUNODOMINANT AREAS THAT CHANGE THE CORRELATION OF PROTECTION OF VACCINES AGAINS FOOT AND MOUTH DISEASE
Discipline
Bioinformatics Challenge model development Challenge study design Clinical trials – efficacy Clinical trials – safety Molecular biology Quality assurance Registration Regulation Safety evaluation Virology
Host species
Buffalo Camels Cats Cattle Dogs Fish Horses Pigs Poultry Small ruminants Wildlife Zoonoses
Pathogen
Bacteria›Brucella Bacteria›Salmonella Viruses Viruses›African swine fever virus Viruses›Arboviruses Viruses›Bluetongue virus Viruses›Bovine viral diarrhoea Viruses›Calicivirus Viruses›Capripoxvirus Viruses›Classical swine fever virus Viruses›Coronavirus Viruses›Feline leukaemia virus Viruses›Foot-and-mouth disease virus Viruses›Herpesvirus Viruses›Infectious salmon anaemia virus Viruses›Influenza virus Viruses›Mareks disease virus Viruses›Newcastle disease virus Viruses›Paramyxoviruses Viruses›Parvovirus Viruses›Porcine circovirus Viruses›Porcine reproductive and respiratory syndrome virus Viruses›Poxviruses Viruses›Rabies virus Viruses›Rotavirus
Stage of vaccine development
Antigen discovery and immunogen design Clinical trials Commercialisation Correlates of protection – immunomonitoring Field trials Pre-clinical trials Vaccine delivery